Placement by AFT Pharmaceuticals

AFT Pharmaceuticals has completed its $73.8m placement, comprising a $10m primary issuance and a sell down by certain major shareholders of $63.8m of existing shares. Approximately 19.7 million shares were sold to existing shareholders and new investors across the Placement, including approximately 2.7 million new shares under the primary issuance, at a price of $3.75 […]